Proton spectroscopy in myotonic dystrophy: Correlations with CTG repeats

Archives of Neurology

Volumn 55, Issue 3, 1998, Pages 305-311

  Chang, Linda ^a   Ernst, Thomas ^a   Osborn, Diane ^a   Seltzer, William ^b,c   Leonido Yee, Maria ^a   Poland, Russell E ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Athena Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 19; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DNA FLANKING REGION; FEMALE; GENE LOCUS; HEART CONDUCTION; HUMAN; MALE; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTON NUCLEAR MAGNETIC RESONANCE; TRINUCLEOTIDE REPEAT;

ADULT; BRAIN CHEMISTRY; BRAIN DISEASES; CHOLINE; CREATININE; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOTONIC DYSTROPHY; PREDICTIVE VALUE OF TESTS; PROTONS; TRINUCLEOTIDE REPEATS;

EID: 0031895697     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.3.305     Document Type: Article

References (56)

1. Johnson K, Shelbourne P, Davies J, et al. A new polymorphic probe which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am J Hum Genet. 1990;46:1073-1081.
2. Harley H, Brook J, Floyd J, et al. Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am J Hum Genet. 1991;49:68-75.
3. Buxton J, Shelbourne P, Davies J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992;355:547-548.
4. Fu Y, Pizzuti R, Fenwick J, et al. An unstable triplet repeat in a gene related to myotonic dystrophy. Science. 1992;255:1256-1258.
5. Jansen G, Mahadevan M, Amemiya C, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet. 1992;1:261-266.
6. Klesert T, Otten A, Bird T, Tapscott S. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet. 1997;16:402-406.
7. Thornton C, Wymer J, Simmons Z, McClain C, Moxley R. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet. 1997;16:407-409.
8. Harper P. Myotonic Dystrophy. 2nd ed. London, England: WB Saunders Co; 1989.
9. Calderon R. Myotonic dystrophy: a neglected cause of mental retardation. J Pediatr. 1966;68:423-431.
10. Bird T, Follett C, Griep E. Cognitive and personality function in myotonic muscular dystrophy. J Neurol Neurosurg Psychiatry. 1983;46:971-980.
11. Woodward J, Heaton R, Simon D, Ringel S. Neuropsychological findings in myotonic dystrophy. J Clin Neuropsychol. 1982;4:335-342.
12. Stuss D, Kates M, Poirier C, et al. Evaluation of information-processing speed and neuropsychological functioning in patients with myotonic dystrophy. J Clin Exp Neuropsychol. 1987;9:131-146.
13. Huber S, Kissel J, Shuttleworth E, Chakeres D, Clapp L, Brogan M. Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol. 1989;46:536-540.
14. Palmer B, Boone K, Chang L, Lee A, Black S. Cognitive deficits and personality patterns in maternally versus paternally inherited myotonic dystrophy. J Clin Exp Neuropsychol. 1994;16:784-795.
15. Brumback R. Disturbed personality and psychological adjustment in myotonic dystrophy: relationship to intellectual/cognitive function and underlying affective disorder (depression). Psychol Rep. 1987;60:783-796.
16. Malloy P, Mishra S, Adler S. Neuropsychological deficits in myotonic muscular dystrophy. J Neurol Neurosurg Psychiatry. 1990;53:1011-1013.
17. Censori B, Danni M, Del Pesce M, Provinciali L. Neuropsychological profile in myotonic dystrophy. J Neurol. 1990;237:251-256.
18. Chang L, Anderson T, Migneco O, et al. Cerebral abnormalities in myotonic dystrophy: cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol. 1993;50:917-923.
19. Glantz R, Wright R, Huckman M, Garron D, Siegel I. Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch Neurol. 1988;45:36-37.
20. Damian M, Schilling G, Bachmann G, Simon C, Stoppler S, Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand. 1994;90:430-436.
21. Censori B, Provinciali L, Danni M, et al. Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions. Acta Neurol Scand. 1994;90:211-217.
22. Fiorelli M, Duboc D, Mazoyer B. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology. 1992;50:91-94.
23. Yoshimura N, Otake M, Igarashi K, Matsunaga M, Takebe K, Kudo H. Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy. Clin Neuropathol. 1990;9:234-239.
24. Kiuchi A, Otsuka N, Namba Y, Nakano I, Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol. 1991;82:1-5.
25. Vermersch P, Sergeant N, Ruchoux M, et al. Specific tau-variants in the brains of patients with myotonic dystrophy. Neurology. 1996;47:711-717.
26. Culebras A, Segarra J, Feldman R. Cytoplasmic inclusion bodies within neurons of the thalamus in myotonic dystrophy: a light and electron microscope study. J Neurol Sci. 1973;19:319-329.
27. Folstein M, Folstein S, McHugh P. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
28. Brook J, McCurrach M, Harley H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;68:799-808.
29. Harley H, Brook J, Rundle S, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992;355:545-546.
30. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987;508:333-348.
31. 1H MR spectroscopy of the frontal lobe. Magn Reson Med. 1996;36:462-468.
32. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain, I: compartments and water. J Magn Reson. 1993;B102:1-8.
33. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain, II: metabolite concentrations. J Magn Reson. 1993;B102:9-19.
34. Damian M, Bachmann G, Herrmann D, Dorndorf W. Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol. 1993;240:8-12.
35. Hashimoto T, Tayama M, Yoshimoto T, et al. Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy. Pediatr Neurol. 1995;12:335-340.
36. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 1993;15:289-298.
37. Redman J, Fenwick RJ, Fu H, Pizzuti A, Caskey C. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA. 1993;269:1960-1965.
38. n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol. 1993;50:85-92.
39. Bruhn H, Frahm J, Merboldt K, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol. 1992;32:140-150.
40. Chang L. In vivo magnetic resonance spectroscopy in HIV and HIV-related brain diseases. Rev Neurosci. 1995;6:365-378.
41. Laubenberger J, Haussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology. 1996;199:805-810.
42. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology. 1997;48:836-845.
43. Moats R, Ernst T, Shonk T, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer's disease. Magn Reson Med. 1994;32:110-115.
44. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology. 1997;203:829-836.
45. Lien Y, Shapiro J, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest. 1990;85:1427-1435.
46. Kimelberg H, O'Connor E, Kettenmann H. Effects of swelling on glial cell function. In: Lang F, Haeussinger D, eds. Interactions in Cell Volume and Cell Function. Heidelberg, Germany: Springer-Verlag; 1993:158-186.
47. Ono S, Inoue K, Mannen T, Kanda F, Jinnai K, Takahashi K. Neuropathological changes of the brain in myotonic dystrophy: some new observations. J Neurol Sci. 1987;81:301-320.
48. Nash S, Giros B, Kingsmore S, et al. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Recept Channels. 1994;2:165-174.
49. Rojas C, Wang J, Schwartz L, Hoffman E, Powell B, Brown R. A methionine to valine mutation in the skeletal muscle sodium channel alpha-subunit in human hyperkalemic periodic paralysis. Nature. 1991;354:387-389.
50. McClatchey A, Van den Bergh P, Pericak-Vance M, et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell. 1992;68:769-774.
51. Koch M, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science. 1992;257:797-800.
52. 1H spectroscopic imaging. Ann Neurol. 1994;36:157-165.
53. Chang L, Ernst T, Strickland T. Neurochemical abnormalities and gender effects in abstinent asymptomatic cocaine users. In: Proceedings of the International Society for Magnetic Resonance in Medicine; April 27-May 31996; New York, NY. Abstract 992.
54. Urenjak J, Williams S, Gadian D, Noble M. Proton nuclear magnetic resonance spectroscopy unambigously identifies different neural cell types. J Neurosci. 1993;13:981-989.
55. Tracey I, Carr C, Guimaraes A, Worth J, Navia B, Gonzalez R. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology. 1996;46:783-788.
56. Thornton C, Johnson K, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994;35:104-107.